InVivoMAb大鼠IgG2b同种型对照，孔血蓝蛋白研究专用

LTF-2单克隆抗体与钥匙孔血蓝蛋白（KLH）反应。由于哺乳动物不表达KLH，这种抗体非常适合在大多数体内和体外应用中用作大鼠IgG2b抗体的同种型匹配对照。

艾美捷InVivoMAb大鼠IgG2b同种型对照，抗锁孔血蓝蛋白：

货号：BXC-BE0090

亚型：大鼠IgG2b，κ

推荐稀释液：InVivoPure pH 7.0稀释液

偶联：未偶联。提供抗体偶联服务。

配方：PBS，pH 7.0 不含稳定剂或防腐剂

内毒素：<2EU/毫克（<0.002EU/微克）由LAL凝胶凝固测定法确定

纯度：>95% 由SDS-PAGE确定

无菌性：0.2微米过滤

生产：在无动物设施中从细胞培养上清液中纯化

纯化：蛋白质G

分子量：150 kDa

储存：抗体溶液应以原始浓度在4°C下储存。不要冷冻。

InVivoMAb大鼠IgG2b同种型对照文献参考：

Bauche, D., et al. (2018). "LAG3(+) Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1(+) Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis" Immunity 49(2): 342-352 e345.

Triplett, T. A., et al. (2018). "Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme" Nat Biotechnol 36(8): 758-764.

Aloulou, M., et al. (2016). "Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells" Nat Commun 7: 10579.

Finkin, S., et al. (2015). "Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma" Nat Immunol. doi : 10.1038/ni.3290.

Zhang, J., et al. (2015). "Micro-RNA-155-mediated control of heme oxygenase 1 (HO-1) is required for restoring adaptively tolerant CD4+ T-cell function in rodents" Eur J Immunol 45(3): 829-842.